Startups
Cilcare
Montpellier, France · Boston, Massachusetts, United States · Paris, France · Tokyo, Japan
Cilcare is a French biotechnology company founded by Celia Belline, Sylvie Pucheu and Marie-Pierre Pasdelou to develop treatments and research technologies for auditory disorders. Its active French SAS was legally created on June 6, 2014 (SIREN 803146125; VAT FR00803146125). Based in Montpellier with operations in the Boston area and additional offices named in Paris and Tokyo, Cilcare studies cochlear synaptopathy, hearing loss, tinnitus and related conditions. It combines investigational drug candidates CIL001 and CIL003, preclinical research services and an Auditory Analytics platform using artificial intelligence and machine learning to characterize hearing function, identify biomarkers and support clinical-study patient selection. Observational studies in diabetes and neurodegenerative disease populations remain research activities; the company has not established a dementia treatment. Its public directory names 46 employees and 12 scientific advisers. An April 18, 2024 announcement confirmed an undisclosed capital infusion involving the University of Vermont Health Network, ARIS, Sofilaro and Sud PME Croissance. On December 4, 2024, Cilcare announced a EUR40 million Series A aggregate that included EUR21 million in its latest financing, naming Shionogi and SPRIM Global Investments as new investors alongside existing shareholders. Its 2017 financing included a verified EUR240,000 Sofilaro investment; the overall amount was described as more than EUR650,000. Research support includes a June 2024 EUR4.2 million France2030 i-Démo award with 40% grant support and a May 2026 FEDER project with support of up to EUR0.6 million over three years. A June 2026 Sanofi license amendment exchanged improved royalty terms for minority equity; no cash investment amount was disclosed.
Team
 Aimo KanntScientific Advisory Board Member |
 Alan FosterScientific Advisor |
 Aloïs BonnetQuality System Manager |
 Aurore MarieGeneral Manager, Japan & Asia |
 Bettina M. CockroftChief Medical Officer |
 Blandine DuvalData Scientist |
 Camille DejeanSenior scientist, Electrophysiology & Tinnitus |
 Camille RochmannEvidence, Value & Access Senior Manager |
 Carolanne CoyatProgram Leader, Histology & ex vivo |
 Celia BellineFounder and Chief Executive Officer |
 Charles VincentLaboratory Technical Manager |
 Chloé PetitPreclinical study manager, Histology |
 Clément VanberguePreclinical Study Manager |
 Dona JayakodyScientific Advisory Board Member |
 Elodie FlaszkaAssociate Director Planning & Resources Management, Senior R&D Manager |
 Frédéric VenailScientific Advisory Board Member |
 Frédérique DefosseJunior Clinical Trial Manager |
 Gautier TejedorPreclinical Study Manager |
 Gaëlle NaertChief Scientific & Operations Officer |
 Hugo LaullierHead of Data & Artificial Intelligence |
 Jean-Hugues MasgnauxScientific Advisory Board Member |
 Julien ChartoireAssistant Lab Technical Manager & Software Engineer |
 Jérôme GeoffroyChief Financial Officer & Chief Digital Officer |
 Jérôme NevouxScientific Advisory Board Member |
 Karine ToupetPreclinical Operation Director & Program Leader |
 Keith DarrowScientific Advisory Board Member |
 Laetitia LeudiereMedical Writer & Assistant Program Manager |
 Louis DelamarreMedical Director of Translational Research |
 Maia De WavrechinAssistant Project Manager |
 Marianne AincyPreclinical Study Manager |
 Marie Peytavy-IzardMarketing & Communication Director |
 Marie-Pierre PasdelouFounder, Chief Compliance Officer |
 Marion SouchalProgram Leader, in vivo & surgery |
 Mark SelfAdministration & Human Resources Manager |
 Mathieu SchueChief Clinical Operations Officer |
 Maxime BourretFull Stack Web Developer |
 Maxime DumayJunior Project Leader & Regulatory Manager |
 Molly KalkerSenior Scientist, Inner ear histology |
 Mélanie BertaProject Manager, Drug Development |
 Patricia MachadoEarly Drug Development & Pipeline Director |
 Philippe Larroze-ChicotReal Estate & Infrastructure Operations Director |
 Preethi SundaramBoard Member (appointed December 2024) |
 Quynh-Anh ArtinianSenior Scientist, Inner ear surgery |
 Regina KelmannSenior Scientist |
 Richard SalviScientific Advisory Board Member |
 Sandra JoppePreclinical Study Manager |
 Sandrine BadouardFinance Manager |
 Sarah GuadagnoExecutive Assistant to Chief Operations Officer |
 Saïd BekkaScientific Advisory Board Member |
 Sebastien DiotHead of US preclinical operations |
 Sheldon DecombeMarket Development Manager |
 Stacy AlvesPreclinical Assistant Research Scientist |
 Stéphane MaisonScientific Advisory Board Member |
 Susanna MalmströmDirector, Sales & Subcontracts |
 Sylvie PucheuFounder, Director of Preclinical Innovation |
 Thomas GerbaudActing Chief Data Officer (external advisor) |
 Véronique BaudouxInterventional Clinical Trial Manager |
 Yves CazalsHonorary President, Scientific Advisory Board |
 Zoe Kaier-GreenClinical Development Audiologist and Trials Manager |